Lantheus to Present at the Jefferies London Healthcare Conference
Lantheus to Present at the Jefferies London Healthcare Conference
BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies London Healthcare Conference at 1:00 p.m. GMT (8 a.m. EST) on Wednesday, November 20.
马萨诸塞州贝德福，2024年11月13日（环球新闻社）-- lantheus控股公司（"lantheus"）（纳斯达克：LNTH）, 该公司是领先的放射性药物公司，致力于帮助临床医生找到、战胜和随访疾病，以提供更好的患者结局。今日宣布，首席财务官兼主管Bob Marshall将于11月20日（星期三）下午1:00（GMT），美东时间上午8:00，在杰富瑞伦敦医疗保健大会上发表演讲。
To access a live webcast of the presentation, please visit the Investors section of the Company's website at . A replay of the webcast will be available on the Company's website for at least 30 days following the live presentation.
要获取演示文稿的实况网络广播，请访问公司网站的投资人部分。从演示文稿实况之后的至少30天内，公司网站上将提供网络广播的重播。
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit .
关于lantheus
Lantheus是领先的放射性制药公司，提供可以帮助临床医生找到、打击和跟踪疾病，从而提供更好的患者结果的重要科学。总部位于马萨诸塞州，在加拿大和瑞典设有办事处，Lantheus已提供放射性药物解决方案超过65年。有关更多信息，请访问该公司网站。
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
联系人：
马克·基纳尼
投资者关系副总裁
978-671-8842
ir@lantheus.com
Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com
梅丽莎·唐斯
通信公关高级董事
646-975-2533
media@lantheus.com
Source: Lantheus Holdings, Inc.
来源: lantheus控股有限公司。
